Skip to main content
MDxHealth SA logo

MDxHealth SA — Investor Relations & Filings

Ticker · MDXH ISIN · BE0974461940 LEI · 549300J3MG9F9B5FY646 BR Human health and social work activities
Filings indexed 940 across all filing types
Latest filing 2023-08-09 Earnings Release
Country BE Belgium
Listing BR MDXH

About MDxHealth SA

https://mdxhealth.com/

MDxHealth SA is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize the diagnosis and treatment of urologic conditions. The company's portfolio of tests is designed to assist clinicians in making more informed decisions. For prostate cancer, its products include Select mdx, which assesses a patient's risk to help determine if a biopsy can be safely avoided; Confirm mdx, which addresses biopsy sampling errors; and the GPS (Genomic Prostate Score) test, a genomic assay that helps guide treatment decisions for men with localized disease. Additionally, the company offers Resolve mdx, a test that aids in selecting appropriate treatment for patients presenting with symptoms of urinary tract infections (UTIs).

Recent filings

Filing Released Lang Actions
PR 2023 08 09 EN.pdf
Earnings Release Classification · 95% confidence The document is clearly formatted as a "NEWS RELEASE" dated August 9, 2023, announcing a specific business development: Cigna expanding coverage for MDxHealth's prostate cancer tests. This type of announcement, focusing on a key operational or commercial achievement, is characteristic of an Earnings Release (ER) or a general press release. Since the content is a specific announcement of a commercial event (coverage expansion) rather than a full quarterly financial report (IR) or a transcript (CT), the most appropriate classification is Earnings Release (ER), as these releases often contain key operational highlights alongside financial context, even if full financials aren't present. It is not a formal regulatory filing like a 10-K or a report publication announcement (RPA) because it is the primary announcement itself, not just a notice that a report is available. The length (8474 chars) is substantial enough to contain more than just a brief notification. Q4 2023
2023-08-09 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes information about shareholder meetings approving a new share option plan and amendments to the Articles of Association. The document is relatively short (2206 characters) and primarily serves as a regulatory update rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-07-05 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a press release dated June 30, 2023, attached as Exhibit 99.1. The document states that the information is being furnished and shall not be deemed "filed" for certain regulatory purposes, indicating it is an announcement or update rather than a full report. The document length is 2067 characters, which is relatively short and consistent with a regulatory filing or announcement rather than a full financial report. There is no substantive financial data or detailed analysis present, only a reference to a press release. Therefore, this document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings like Form 6-K that do not fit other categories.
2023-07-03 English
PR 2023 06 30 EN.pdf
AGM Information Classification · 99% confidence The document explicitly announces the results of an 'Extraordinary General Shareholders' Meeting' (EGM). It details the resolutions passed, such as the issuance of a new share option plan and the renewal of authorization for share capital increase. This content directly relates to shareholder voting outcomes and meeting proceedings. The most fitting category is 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the outcome of the shareholder vote.
2023-06-30 English
PR 2023 06 30 FR.pdf
AGM Information Classification · 98% confidence The document is titled "MDxHealth annonce les résultats de son assemblée générale extraordinaire des actionnaires" (MDxHealth announces the results of its extraordinary general meeting of shareholders). It explicitly mentions the holding of an 'assemblée générale extraordinaire des actionnaires' (AGE) and details the resolutions voted upon, such as the issuance of a new share option plan and capital increase authorization. The key outcome is the announcement of the results of this shareholder meeting. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2023-06-30 French
3-Attendance-Form-EN.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled 'ATTENDANCE FORM FOR SECURITY HOLDERS EXTRAORDINARY GENERAL MEETING' and details the procedures, deadlines, and required information for shareholders wishing to attend the EGM scheduled for June 30, 2023. This type of material, which solicits attendance and provides voting/participation instructions ahead of a general meeting, falls under the category of Proxy Solicitation & Information Statement (PSI). It is not the final voting results (DVA), the meeting presentation (AGM-R), or a general regulatory announcement (RNS).
2023-06-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.